Poster Session 1 — ASN Events
8:00PM - 10:00PM
Pre-Conference Terrace
Sponsored by:

Wines kindly sourced by auscellardoor+logo.JPG


Synthesis of Acid-Stable Sulfated Anti-Thrombotic Peptides (#72)

8:00 PM
Stijn M Agten

Developing Cell Permeating Cyclic Peptides for use as Potential New Anti-Infective Agents (#74)

8:00 PM
Nicholas Barlow

Comparative study of properties of familial Alzheimer's disease (FAD) mutants of the amyloid-β peptide (#75)

8:00 PM
Sritama Bose

Total chemical synthesis of single domain trefoil factor peptides (#76)

8:00 PM
Nayara Braga Emidio

Engineering truncated α-conotoxin Vc1.1 analogues for treatment of chronic pain (#79)

8:00 PM
James T Daniel

Do You Care About The Quality of Peptides That You Synthesize? (#82)

8:00 PM
Andrew Duggan

In vitro selection for macrocyclic peptides that regulate intracellular TGFβ signaling (#83)

8:00 PM
Christopher Hipolito

Development of scaffold-based peptide scavengers for inhibition of autoantibodies in rheumatoid arthritis (#84)

8:00 PM
Camilla Eriksson

Mimetic peptides of mortalin, the mitochondrial stress protein 70 (#85)

8:00 PM
Zvi Fishelson

Identification and Expression of Novel Chemokine-Inhibitory Evasin Proteins (#86)

8:00 PM
Charlotte Franck

Challenging breast cancer brain metastases development with the natural peptide PvD1 (#87)

8:00 PM
Diana Gaspar

Harnessing the utility of peptides to target bacterial membrane function (#88)

8:00 PM
Karl A Hansford

The Importance of Choosing the Right Model for the Characterization of Peptide-Membrane Interactions (#89)

8:00 PM
Imad Younus Hasan

Application of 3-nitro-2-pyridinesulfenyl (Npys) derivatives to chemical biology, peptide chemistry and medicinal chemistry (#90)

8:00 PM
Yoshio Hayashi

Sniffing oxytocin: Investigating the pathway of oxytocin to the central nervous system (#91)

8:00 PM
Anke Hering

A fluorescent peptide constraint to induce secondary structure (#92)

8:00 PM
Aimee Horsfall

Two different types of anti-angiogenic drugs with a similar dose-efficacy relationship: coincidence or correlative? (#93)

8:00 PM
Jialiang Hu

An integrin αvβ3 antagonistic modified peptide inhibits tumor growth through inhibition of the ERK and AKT signaling pathways (#94)

8:00 PM
Lirong Hu

Synthesis and biological evaluation of Teixobactin analogues (#96)

8:00 PM
Yahya E. Jad

Design of ultra-stable, bioactive cyclic peptides (#100)

8:00 PM
Quentin Kaas

OBOC combinatorial peptide libraries for identification of targetable membrane proteins as bone metastasis mediators in breast cancer (#101)

8:00 PM
Daniela Kalafatovic

Pelgipeptin L, a new type of pelgipeptin family isolated from Paenibacillus elgii (#103)

8:00 PM
Jueun Kim

In silico discovery of novel insect defensin and defensin-like peptides reveals novel templates for antimicrobial drug development (#104)

8:00 PM
Johannes Koehbach

Design and development of a family of thrombin-inhibiting peptides (#105)

8:00 PM
Cho Yeow Koh

Comparision of Fmoc-, Boc- and fragment condensation strategies in the synthesis of peptide-6-amino-D-luciferin conjugates (#106)

8:00 PM
Anita K Kovacs

Pharmacokinetic assessment of orally active analgesics built on the cyclotide scaffold (#107)

8:00 PM
Aaron G Poth

An integrin antagonist peptide AP25 recruits integrin to membrane lipid rafts to regulate HUVEC migration (#108)

8:00 PM
Mengwei Li

A new generation of synthetic xanthone-based peptidomimetics as antibiotics: from discovery to preclinical study and translational application   (#109)

8:00 PM
Shouping Liu

High Performance Flash Chromatography. An Alternative Technique to Rapidly and Efficiently Purify Crude Synthetic Peptides. (#112)

8:00 PM
Amit Mehrotra

Synthesis and solution structure of a polypeptin, PE2. (#113)

8:00 PM
Simon J Mountford

Effective analgesic treatment of post-surgical pain via NaV1.7 inhibition (#114)

8:00 PM
Alexander Mueller

The patellamides: in vitro enzymatic synthesis and stereochemical challenges (#115)

8:00 PM
Brunello Nardone

3D structure-based design and synthesis of apratoxin A mimetics (#116)

8:00 PM
Yuichi Onda

A Cleavable bis-linker Strategy for the Chemical Synthesis of Heterodimeric Peptides (#117)

8:00 PM
Nitin Patil

Downsizing proto oncogene cfos to short cell permeable helix constrained peptides (#118)

8:00 PM
Samuel R Perry

Development of cyclic-peptide scaffolds to target intracellular protein-protein interactions in cancer cells (#120)

8:00 PM
Gregoire Philippe

Efficient synthesis of 84-mer human Parathyroid hormone for the study of osteoporosis and hypoparathyroidism (#121)

8:00 PM
Cyf Ramos-Colon

Fast and efficient automated, on-resin synthesis of disulfide-bridged type-II diabetes-related peptide Amylin  (#122)

8:00 PM
Cyf Ramos-Colon

Targeting Gram-negative ‘Superbugs’ with Next-Generation Polymyxin Antibiotics (#123)

8:00 PM
Kade D Roberts

Cyclic peptides as building blocks for novel nanotubes (#124)

8:00 PM
Jo Sampson

Rational design of variant PuroA antimicrobial peptides and revealing the mechanism of action of PuroA using live-cell imaging (#125)

8:00 PM
Nadin Shagaghi

Parallel and antiparallel cyclic D/L peptide nanotubes (#126)

8:00 PM
Mitchell R Silk

Total synthesis of celogentin C on solid phase synthesis (#127)

8:00 PM
Varsha Thombare

Why are dimers of the NPY C-terminus superpotent, selective Y receptor ligands? (#128)

8:00 PM
Philip Thompson

CESI-MS detection and quantitation of neuropeptides (#129)

8:00 PM
Jim Thorn

Functional evaluation of intracellular delivery peptides based on the EGF receptor dimerization arm sequences (#130)

8:00 PM
Kei Toyama

Tachyplesin I – hairpin peptide with anticancer properties (#131)

8:00 PM
Felicitas Vernen

Synthetic Molecular Evolution of Peptide Antibiotics (#132)

8:00 PM
William C Wimley

Europium-labeled synthetic C3a protein as a novel fluorescent probe for human complement C3a receptor (#133)

8:00 PM
Chongyang Wu

Synthesis of L-boronophenylalnine and L-carboranylalanine bearing peptides by ribosome (#134)

8:00 PM
Yizhen Yin

The structural optimization of Integrin Alpha 6 Targeting Peptides (#135)

8:00 PM
Lihuai Qin